- All site RSS

News

Skolkovo startups launch crowdfunding campaigns amid reality TV show competition
Seven Skolkovo startups have launched crowdfunding campaigns as they compete against each other in a reality TV show on Russian TV titled “An Idea Worth a Million.” Motorica has made 3D-printed...

Five ingredients for an innovation-friendly organisation
“A new idea is delicate. It can be killed by a sneer or a yawn; it can be stabbed to death by a quip and worried to death by a frown on the right man's brow,” the Roman poet Ovid wrote...

Investors buy into R-Sept’s robotic milking system
R-Sept, a Skolkovo resident startup that has developed a robotic milking station for cows, has raised 10 million rubles ($170,000) in funding from two investors, the company told VC.ru last week. Alexey...

On November 14-15 annual conference "Clinical Trials in Russia" sponsored by IPHARMA will be held
On November 14-15 the sixth international conference of the Adam Smith Institute "Clinical Research in Russia" will be held. IPHARMA is one of the sponsors of the conference. Under the program...

Russia advances five places in World Bank Doing Business rating
Russia moved up to 35th place in the Doing Business 2018 report released by the World Bank, five places up from its previous position. The Skolkovo Technopark offers a range of services to small tech startups...

East-west innovations: Skolkovo-Far East partnership ‘destined for success’
Despite the 9,000 kilometres between them, the Skolkovo innovation centre outside Moscow and Russia’s Far Eastern Federal University (FEFU) in Vladivostok have a lot in common. They were both created...

Russian fintech startups introduced to global community at Sibos conference
Three Skolkovo fintech startups presented their solutions to the global financial services world at the recent Sibos conference in Toronto, after winning the chance to do so in a competition earlier this...

IPHARMA received the Ministry of Health permission to conduct Phase I trial of Khondrolux®
On October, 30 IPHARMA received the Ministry of Health permission to conduct Phase I trial of Hondrolux®. Protocol № ОА-CLX-01 “Double-blind, randomized, placebo-controlled study to access safety...

The Skolkovo-Oerlikon Additive manufacturing (AM) Startup Challenge shows the way forward for additive manufacturing on Open Innovations
Skolkovo, Russia – October 18, 2017 – The final of the Skolkovo-Oerlikon AM Startup Challenge is being held on October 18, 2017 at the Skolkovo Innovation Center in frame of Open Innovation...